The Ozempic Paradox: Why Weight-Loss Drugs May Be Making You Stop Moving

The Debate

By July 1, an estimated 14 million overweight or obese Medicare beneficiaries will become eligible for GLP-1 weight-loss drugs like Wegovy and Zepbound at just $50 a month. It's being called one of the biggest drug rollouts in American history. The promise? A simple injection or pill that melts away pounds without the grueling work of diet and exercise. But here's the question nobody at the press conference is asking: What happens to your muscles when you lose weight without...